CCL Biomedical, Inc.

224 N. Washington Street
Havre de Grace, MD 21078
2 Employees

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $1.51MM
First Award Date 01/01/03
Most Recent Award Date 02/27/13

Key Personnel

Last Name Name Awards Contact
Lamba Nina M Lamba 6 Message
Lamba-Kohli Nina M Lamba-Kohli 1

7 Awards Won

Phase 1 SBIR

Agency: Defense Health Program
Topic: DHP12-011
Budget: 02/27/13 - 10/04/13

The goal of this Phase I SBIR proposal is to develop and evaluate a new antimicrobial coating to augment infection control in medical care settings. Laboratory and clinical studies have shown that bacteria can survive for weeks on items found in hospital patient rooms. Such items and are believed to play a role in the transmission of infectious ...

Phase 2 SBIR

Agency: National Science Foundation
Topic: 2009
Budget: 01/01/09 - 12/31/09

This Small Business Innovation Research Phase II project focuses on the development of patented antimicrobial compounds to provide superior infection control to textiles. 5-10% of patients admitted to hospitals in the US acquire an infection while in hospital. Consequences of hospital-acquired infections (HAIs) include prolonged hospital stays,...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 04/08/08 - 03/31/10

DESCRIPTION (provided by applicant): Each year, 5-10% of patients admitted to acute care hospitals in the United States (1.75- 3.5 million people) acquire an infection while in hospital. Consequences of hospital-acquired (nosocomial) infections include prolonged hospital stays, increased pain and discomfort for the patient, and even death. The n...

Phase 1 SBIR

Agency: National Science Foundation
Topic: 2007
Budget: 01/01/07 - 12/31/07

This Small Business Innovation Research (SBIR) Phase I project aims to develop a novel antimicrobial compound to provide active infection control to textiles that will be applied as a finishing treatment. Each year, 5-10% of individuals admitted to U.S. hospitals acquire an infection during treatment. Consequences of these infections include pro...

Phase 2 STTR

Institution: University of Delaware

Agency: National Science Foundation
Topic: 2006
Budget: 01/01/06 - 12/31/06

This Small Business Technology Transfer (STTR) Phase II project proposes the development of a unique family of biocidal polymers that have been shown to be non-leaching, and do not require regeneration or refreshment of activity. The Phase I study demonstrated the synthesis of these polymers containing potent broad-spectrum biocides. The polyme...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/03 - 06/30/05

DESCRIPTION (provided by applicant): Hospital acquired infections are on the increase and compromise the quality and cost-effectiveness of health care. A significant number of device-associated infections occur with urinary catheters. New and effective strategies to supplement and complement traditional infection control practices are urgentl...

Phase 1 STTR

Institution: University of Delaware

Agency: National Science Foundation
Topic: 2003
Budget: 01/01/03 - 12/31/03

This Small Business Technology Transfer (STTR) Phase I proposes to develop antibacterial surfaces and textiles for commercial applications. A series of novel potent dendrimer biocides has been identified, which can be used alone to kill microorganisms, or bound to polymer substrates to produce non-leaching biocidal polymers. The aim of this pr...